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Background: Trisomy 18 (T18) and trisomy 13 (T13) are the second and third commonest autosomal aneuploidy
syndromes respectively. While specific aspects of affected pregnancies have been documented in the literature,
few studies document the overall natural history of the trisomies. This study aimed to examine the natural history
(including diagnosis, pregnancy outcome, complications and survival) of T18 and T13 pregnancies in a setting
where termination of pregnancy for fetal abnormality is not available.
Methods: Cases were identified using birth registers, labour ward records, annual reports, medical records,
ultrasound reports and reports from prenatal genetic testing. All identified T18 and T13 pregnancies in the study
region from 2001 to 2012 were included. Individual chart reviews were performed for each case. Data were
analysed using SPSS Version 20.
Results: Forty-six T18 and twenty-four T13 pregnancies were identified. Most T18 cases (65%) were diagnosed
prenatally, while only one third (33%) of T13 cases were prenatally diagnosed. Only three T18 pregnancies and one
T13 pregnancy were electively terminated. A proportion of undiagnosed infants were delivered by emergency
caesarean section. 48% (T18) and 46% (T13) infants survived following birth, for a median of 1.5 days (T18) and
7 days (T13). One T13 infant is currently alive over one year of age.
Conclusions: This large series provides information for professionals and women regarding the natural histories of
trisomies 18 and 13. These pregnancies can go undiagnosed antenatally without routine anomaly scanning. While
many fetuses die in-utero, postnatal survival is possible.
Keywords: Trisomy 18, Trisomy 13, Aneuploidy, PregnancyBackground
Trisomy 18 (T18) is the second commonest autosomal
aneuploidy after Trisomy 21, with an approximate pre-
valence of 5.05 per 10,000 births in the region in which
this study was conducted (Cork, Ireland). Trisomy 13
(T13) is the third commonest autosomal aneuploidy
with an approximate local prevalence of 2.16 per 10,000
births [1]. In the region studied, there were 90,424 live
births in total during the years 2001–2012 inclusive [2],
making these aneuploidy syndromes a worthy research
topic. These syndromes are associated with multisystem* Correspondence: k.odonoghue@ucc.ie
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nal, gastrointestinal and skeletal malformations, which
have been described in the literature [3-6].
In the published literature, more studies of T18 preg-
nancies are available. Most concentrate on specific as-
pects of the pregnancies, including risk of fetal loss [7]
and survival time, while all [8] report a high risk of
spontaneous fetal loss, with pregnancy loss rates ranging
from 72% to 87% for T18, and between 49% and 66% for
T13 pregnancies [8,9]. The majority of liveborn T18 and
T13 infants (>90%) in most studies survive less than one
year, with some reports noting a significantly increased
survival time for T18 females when compared with males
[10,11]. A large Texas-based study by Vendola et al. [12]ioMed Central Ltd. This is an open access article distributed under the terms of
tp://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Houlihan and O’Donoghue BMC Pregnancy and Childbirth 2013, 13:209 Page 2 of 9
http://www.biomedcentral.com/1471-2393/13/209reported a 3% one year survival rate for both T18
and T13 infants.
While few infants with trisomy 18 survive past one
year of life, a review by Cereda et Carey [5] reported that
approximately half of affected babies live longer than
one week. A study by Baty et al. [13] reported a much
greater one-year survival rate of 42% for T18 infants and
38% for T13 infants, however, this study was based on
data collected from questionnaires completed by mem-
bers of S.O.F.T. (Support Organisation for Trisomy 18,
13 and Related Disorders), which may have resulted in
non-response bias. The median reported survival time of
affected liveborn infants varies between 3 and 15 days
for both trisomies [8-10,14,15]. Case reports of T18 and
T13 individuals surviving for much longer periods of
time have also been published: Petek et al. [16] described
a nineteen year old girl with a full T18 karyotype, Smith
et al. [17] reported an eleven-year-old with T18, and in a
survey by Bruns et al. [6], survival times of 103.3 months
were reported by mothers of 13 trisomy 18 newborns
who were still alive at the time of participation in the
study. Redheendran et al. [18] reported an eleven and a
nineteen year old with T13 karyotypes.
The prevalence of both T18 and T13 has increased in
recent years. One United Kingdom-based study [19] re-
ported an increase in prevalence from 0.20 to 0.65 per
1,000 births for trisomy 18 and from 0.08 to 0.23 per
1,000 births for trisomy 13 between the years 1985 to
2007. This change has been attributed to increasing ma-
ternal age and increased prenatal screening for fetal aneu-
ploidies, which is now recommended for all pregnancies
by the Royal College of Obstetricians and Gynaecologists
[20]. In contrast, in the Republic of Ireland, where our
series is based, prenatal screening for fetal aneuploidy is
not part of routine antenatal care. There is no national
policy on the provision of prenatal screening for aneu-
ploidy. In an Irish study, Lynch and Malone [21] found
that while 72% of healthcare professionals surveyed be-
lieved that detailed ultrasound scans should be performed
for fetal anomaly, only 10% routinely discussed prenatal
screening for fetal aneuploidy. This is in spite of findings
that more than 73% of Irish pregnant woman would avail
of fetal anomaly scans or biochemical testing if it was
made available to them [22].
Few studies report data relating to the entire natural
history of affected pregnancies. The published literature
on these trisomies is limited by small sample size and
high rates of elective termination of pregnancy following
prenatal diagnosis (up to 78%) [9]. Elective termination
of pregnancy for fetal abnormality is illegal in the Republic
of Ireland. While Irish women can access termination
of pregnancy in other jurisdictions, the majority tend
to allow pregnancies diagnosed with fetal abnormality
to continue. Therefore, we have an ideal opportunityto conduct observational studies on pregnancies af-
fected by trisomies 18 and 13.
Our aim was to study the natural history of pregnan-
cies with a fetal or neonatal diagnosis of trisomies 18
and 13. In doing so, we aimed to provide clinicians with
a better indication of the course of affected pregnancies,
in order to assist with counselling and management and
to improve the quality of care. Knowledge of the out-
come, complications and infant survival time of previous
T18 and T13 pregnancies could assist parents and obste-
tricians in making more informed decisions related to
the management of affected pregnancies in the future.
Methods
This was a retrospective descriptive cohort study. Ethical
approval for the proposed study was granted from the
Cork Research and Ethics Committee (CREC) of the
Cork Teaching Hospitals in November 2011. All preg-
nancies and infants with a diagnosis of T18 or T13 cared
for in all hospitals operating in the Cork region during
the period from January 2001 to July 2012 were in-
cluded. These were the Erinville Hospital (closed 2007),
St. Finbarr’s maternity hospital (closed 2007), the mater-
nity unit in the Bons Secours Hospital (closed 2007) and
Cork University Maternity Hospital, which was formed
from the amalgamation of all three maternity units and
opened in April 2007. All of the women in the study were
booked for consultant-led antenatal care at one of these
units. Input from a consultant obstetrician was available at
each antenatal visit for all pregnancies involved in the
study and a consultant obstetrician reviewed all women
with a fetal diagnosis of trisomy 18 or trisomy 13.
Cases were identified using birth registers, labour ward
records, annual reports, medical records, ultrasound
reports and reports from prenatal genetic testing. Iden-
tified cases were then verified using the EUROCAT
(European surveillance of congenital anomalies) Cork and
Kerry Registry, which records data for the region studied.
Pregnancies studied all had a diagnosis of T18 or T13 con-
firmed by karyotype either prenatally or postnatally. Triso-
mies of the long (q) arm of chromosome 18 or 13 were
also included. Mosaic cases were excluded from the study.
Following verification, maternity charts were requested
from the relevant storage facilities and individual case re-
views were subsequently performed. Information was col-
lected in relation to parental demographics, gestation at
diagnosis, method of diagnosis, structural abnormalities,
pregnancy complications (maternal and fetal), pregnancy
outcome, timing of fetal or neonatal death, mode of deli-
very, delivery complications and neonatal survival time.
All data collected was anonymised and entered into
a Microsoft® Excel® 2010 spread sheet, saved onto a
password-protected secure external hard drive. The data
was then imported into SPSS® Statistics Version 20 and
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with SPSS. An assessment of normality was performed for
certain variables in the dataset, using histograms, normal
Q-Q plots, detrended Q-Q plots and the Shapiro-Wilk
est. Descriptive statistics were used to present the data.
Continuous variables were summarised as medians and
interquartile ranges (IQR) (nonparametric data). Cate-
gorical variables were summarised as percentages. The
Chi-Squared goodness of fit test, Mann–Whitney U test
and exact hypothesis test with binomial distribution were
performed to analyse data. Statistical significance was re-
ported when a two-sided P value was found to be less
than or equal to 0.05.
Results
Fetal characteristics
Forty-six cases of T18 and twenty-four cases of T13
were identified. One T13 infant had an unbalanced
Robertsonian translocation t (13; 14), in which three
copies of the long arm of chromosome 13 were detected.
The remainder of the cases were full trisomy karyotypes.
One T18 mosaic case was identified; however, this was
subsequently excluded from the series as two thirds of
the infant’s cells were found not to contain the trisomy,
and the infant did not demonstrate a characteristic T18
phenotype. Two T18 infants were part of twin gesta-
tions; one dichorionic diamniotic twin pregnancy and
the other a monochorionic diamniotic pregnancy. One
T13 infant was part of a dichorionic diamniotic twin
pregnancy. In all twin pregnancies, the other twin had a
normal karyotype and had an uncomplicated delivery.
Gender distribution for the T18 and T13 groups is
shown in Table 1. There was no significant difference
between the numbers of overall or liveborn T18 male
and female cases, although 75% more females than males
were present in the liveborn group. Twice as many male
than female T13 cases were identified, with the male to fe-
male ratio rising to 9:2 when only those fetuses that were
born alive were considered. The greater number of male
than female T13 liveborn infants was not found to be
statistically significant (p = 0.065).
Parental characteristics
Thirty seven per cent (17/46) of women carrying T18 fe-
tuses and thirty three per cent (8/24) of those carryingTable 1 Gender distribution for the T18 and T13 cohort
Male Female P-value
Overall T18 21 24 0.655
Live born T18 8 14 0.201
Overall T13 14 7 0.127
Live born T13 9 2 0.065
Gender distribution for the T18 and T13 cohort.T13 fetuses had a history of a previous miscarriage. The
median parity for mothers of both trisomies was one
(T18 IQR 0–2; T13 IQR 0–2). The median maternal age
at delivery was 38 years (IQR 34–40 years) for T18 preg-
nancies and 35 years (IQR 28.5-38 years) for T13 preg-
nancies. The proportion of mothers over 35 years of age
was 74% for T18 and 54% for T13, which was signifi-
cantly higher for both trisomies than the 28% for all ma-
ternities in the same region [2]. (T18: X2 (1, n = 46) =
51.364, p < 0.001) (T13: X2 (1, n = 24) = 8.987, p = 0.03).
No parents had previously conceived a T18 or T13 fetus,
however, one 39-year old T18 mother had a trisomy 21
pregnancy the previous year. Six parents of T18 fetuses
and two of T13 fetuses later underwent karyotyping. All
were subsequently found to have normal karyotypes, in-
cluding the parents of the T13 fetus with the t (13; 14)
translocation and the parents who had conceived both a
trisomy 18 and a trisomy 21 fetus.
Diagnosis of trisomy
Sixty five per cent (30/46) of T18 cases were prenatally
diagnosed, in comparison with only thirty three per cent
(7/21) of T13 cases. Three T13 cases that ended in mis-
carriage in the first trimester were excluded from these
figures, as they died in-utero before an ultrasound scan
was performed. The median gestation at diagnosis was
22 weeks for T18 (IQR 15–31.5 weeks) and 20.5 weeks
for T13 (IQR 15.5-28 weeks). The most common rea-
sons for invasive diagnostic testing were abnormalities
detected on routine ultrasound scans, polyhydramnios
and small for gestational age fetuses. The commonest
fetal abnormality detected on ultrasound scans was
increased nuchal translucency (nine T18 cases; three
T13 cases). None of the women studied underwent
first or second trimester prenatal screening for fetal
aneuploidy. Following the opening of Cork University
Maternity Hospital rates of prenatal diagnosis increased
from 42.9% to 87.5% for T18 and from 16.67% to 61.5%
for T13. Using Fisher’s exact probability test, this in-
crease in prenatal diagnosis was found to be statisti-
cally significant for the T18 cases (p = 0.048). While
the rate of prenatal diagnosis for T13 fetuses increased
by almost 45% in the period following the opening of
CUMH, this was not found to be statistically signifi-
cant (p = 0.354). Of the 17 T18 pregnancies in which
a detailed structural anomaly scan was performed, 14
(82%) T18 fetuses were antenatally diagnosed. Six
structural anomaly scans were performed during T13
pregnancies and three (50%) of these fetuses were
prenatally diagnosed.
Congenital defects
The congenital defects reported for the T18 and T13
cases are shown in Table 2. For the T18 fetuses, the
Table 2 Structural abnormalities for T18 and T13 cohorts
Trisomy 18
(N = 46)
Trisomy 13
(N = 24)
Cardiac
Ventricular septal defect 16 (35%) 5 (21%)
Transposition of Great Arteries 1 (2%) 2 (8%)
Patent ductus arteriosus 1 (2%) 1 (4%)
Cerebral
Holoprosencephaly 0 7 (29%)
Cerebral ventriculomegaly 4 (9%) 3 (13%)
Microcephaly 1 (2%) 3 (13%)
Dandy Walker variant 1 (2%) 2 (8%)
Structural
Cleft lip/palate 4 (9%) 11 (46%)
Talipes/rockerbottom feet 10 (22%) 6 (25%)
Clenched hands 9 (20%) 1 (4%)
Polydactyly 0 5 (21%)
Low set ears 2 (4%) 4 (17%)
Short long bones 4 (9%) 0
Overlapping fingers 3 (7%) 1 (4%)
Micrognathia 3 (7%) 0
Ocular hypotelorism 1 (2%) 2 (8%)
Syndactyly 2 (4%) 0
Clinodactyly 1 (2%) 1 (4%)
Prominent forehead 1 (2%) 1 (4%)
Gastrointestinal
Small/absent stomach 6 (13%) 2 (8%)
Omphalocele 6 (13%) 0
Echogenic bowel 1 (2%) 3 (13%)
Umbilical herniation 1 (2%) 1 (4%)
Respiratory
Pleural effusion 4 (9%) 0
Diaphragmatic hernia 4 (9%) 0
Renal
Enlarged/cystic kidneys 4 (9%) 5 (21%)
Structural abnormalities for T18 and T13 cohorts.
Table 3 Structural abnormalities for T18 and T13 cohorts
who nderwent detailed anomaly scans
Trisomy 18
(N = 17)
Trisomy 13
(N = 6)
Cardiac
Ventricular septal defect 11 1
Transposition of Great Arteries 1 0
Patent ductus arteriosus 0 1
Cerebral
Holoprosencephaly 0 2
Cerebral ventriculomegaly 2 0
Microcephaly 1 1
Dandy Walker variant 1 1
Structural
Cleft lip/palate 2 4
Talipes/rockerbottom feet 5 2
Clenched hands 5 1
Polydactyly 0 1
Low set ears 1 0
Short long bones 3 0
Overlapping fingers 0 1
Micrognathia 2 0
Ocular hypotelorism 1 1
Syndactyly 2 0
Gastrointestinal
Small/absent stomach 3 1
Omphalocele 4 0
Umbilical herniation 1 0
Respiratory
Pleural effusion 1 0
Diaphragmatic hernia 3 0
Renal
Enlarged/cystic kidneys 1 3
Structural abnormalities for T18 and T13 cohorts who underwent detailed
anomaly scans.
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defect (16/46; 35%) and abnormal posturing of the hands
(9/46; 20%) or feet (10/46; 22%). The commonest ab-
normalities identified in T13 fetuses were a cleft lip and/
or palate (11/24; 46%), holoprosencephaly (7/24; 29%)
and talipes or rocker bottom feet (6/24; 25%). A detailed
structural anomaly scan was carried out in seventeen
T18 (17/46; 37%) and six T13 (6/24; 25%) pregnancies
to further investigate abnormalities detected on routine
ultrasound scans, most commonly increased nuchal trans-
lucency (2 T18) and intrauterine fetal growth restriction(16 T18; 3 T13). The structural anomalies specific to those
pregnancies in which a detailed anomaly scan was per-
formed are shown in Table 3. Post mortems were
only carried out in two T18 (2/46; 4%) and two T13
cases (2/24; 8%).Pregnancy outcome
The outcome for the T18 and T13 pregnancies is shown
in Figure 1 and Figure 2 respectively. Almost half of T18
(22/46; 48%) and T13 (11/24; 46%) pregnancies resulted
in the delivery of a liveborn infant. Of note, only three
T18 cases (6%) and one T13 case (4%) were electively
terminated.
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Figure 1 T18: Pregnancy outcome, mode of delivery (live born cases) and indications for caesarean section. *Miscarriage: Fetal death
in-utero before twenty weeks gestation. **Antepartum death: Fetal death in-utero at or after twenty weeks gestation.
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Thirty-five T18 fetuses (35/46; 76%) and twelve T13 fe-
tuses (12/24; 50%) were noted to be small for gestational
age. The most common pregnancy complication identi-
fied was polyhydramnios, which was present in thirteen
T18 pregnancies (13/46; 28%) and three T13 pregnancies
(3/20; 15%) in the second and third trimesters. Antepar-
tum haemorrhage occurred in eight T18 (8/46; 17%)
pregnancies and four T13 (4/24; 17%) pregnancies; all
were of a small quantity and resolved spontaneously.
Pre-eclampsia was reported in two T18 (2/36; 6%) and
two T13 (2/17; 12%) pregnancies. The deliveries of the
liveborn T18 and T13 fetuses were largely uncompli-
cated. One T18 mother developed an acute stress reac-
tion requiring psychiatric intervention following the
birth of her baby, whose trisomy was not antenatally di-
agnosed. One T13 mother developed endometritis fol-
lowing delivery.Gestation at delivery
The median gestational age at delivery was 36.5 weeks
(IQR 33.75 – 40 weeks) for T18 liveborn infants and
38 weeks (IQR 35–40 weeks) for T13 liveborn infants.
Eleven (50%) T18 infants and 2 (18%) T13 infants were
delivered preterm. The most common reason for preterm
delivery was obstetric intervention because of concerns re-
garding fetal wellbeing and poor growth detected on ultra-
sound scans in undiagnosed fetuses (5 T18 cases; 2 T13
cases). The other T18 fetuses that were delivered prema-
turely either underwent spontaneous labour at an early
gestation (4 cases), or the fetus was prenatally diagnosed
and the decision to deliver prematurely was made by the
involved obstetrician in each case (3 cases).
Mode of delivery
The mode of delivery for the liveborn T18 infants is
shown in Figure 1. A high proportion of cases were
6Miscarriage
24 T13 fetuses
11
Live birth
1
Intrapartum death
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Antepartum 
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2
Fetal 
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1
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Figure 2 T13: Pregnancy outcome, mode of delivery (live born cases) and indications for caesarean section.
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were delivered by emergency caesarean section and
seven infants (7/22; 32%) by elective caesarean section.
The mode of delivery for the liveborn T13 infants is
shown in Figure 2. While the majority (8/11; 73%) were
born by normal vaginal delivery, two cases (2/11; 18%)
were delivered by emergency caesarean section and one
case (1/11; 9%) by elective caesarean section. The most
common indication for emergency caesarean section in
both groups was distress in an undiagnosed fetus, as re-
ported in six liveborn T18 infants (6/22; 27%) and two
liveborn (2/11; 18%) T13 infants.
Survival time
The survival time for live born T18 and T13 infants is
shown in Figure 3. The 22 T18 live born infants survivedfor a median time of 1.5 days (range; one hour-sixteen
weeks). One female T18 infant (born 2001) had an un-
known duration of survival but it is highly likely that she
died in the early neonatal period as no hospital record
was found for her after birth. The female T18 liveborn
infants survived for a longer period than the male live-
born infants. This was found to be statistically significant
using the Mann–Whitney U test (p = 0.016). The median
survival for the eleven liveborn T13 infants was seven
days (range; fifteen minutes- over one year). Of note,
one male T13 liveborn infant (born October 2011) is still
alive at two years of age. No T18 or T13 liveborn
received invasive ventilation or cardiovascular support
following birth. “Comfort care” was practiced, and the
decision was made not to perform fetal monitoring during
labour for 4 T18 and 2 T13 liveborn infants.
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Figure 3 Survival time for liveborn T18 and T13 cases. The definite survival time for one T18 liveborn infant is unknown and therefore unable
to be represented in bar chart.
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Main findings
This study reports all identified T18 and T13 pregnan-
cies in the Cork region over an 11-year period from
January 2001 to July 2012. Our cohort of forty six T18
pregnancies and twenty-four T13 pregnancies is one of
the largest recent case series available. Our study identi-
fied 46 T18 (47 + 18) and 23 T13 (47 + 13) cases diag-
nosed between January 2001 and June 2012, in addition to
one unbalanced Robertsonian translocation (46 t(13; 14))
who demonstrated the characteristic phenotypical features
of a T13 karyotype. The median maternal age of both tri-
somy cohorts was significantly older than the median ma-
ternal age of the general population. Only three T18 and
one T13 pregnancy were electively terminated after diag-
nosis. The median gestation at diagnosis for both triso-
mies was in the second trimester (T18 22 weeks; T13
20.5 weeks) and the most common indications for invasive
diagnostic testing were abnormalities detected on ultra-
sound scans, polyhydramnios and concern with regard to
fetal growth. The rate of diagnosis for both T18 and T13
increased following the opening of the local large tertiary
referral hospital. Congenital defects in multiple organ sys-
tems were reported for both trisomies, however the per-
centage of fetuses affected was lower than that reported in
other studies [11,23]. This is likely due to the fact that
detailed second-trimester structural anomaly scans were
performed in only seventeen (37%) T18 and six (25%)
T13 pregnancies.
Eleven T18 liveborn infants and two (18%) T13 live-
born infants were delivered preterm, most commonly as
a result of obstetric intervention due to concerns re-
lating to fetal wellbeing. A large proportion of T18 and a
smaller proportion of T13 infants were delivered by emer-
gency caesarean section, the most common indication forwhich was concern for fetal wellbeing in undiagnosed
pregnancies. The majority of pregnancies and births
for both trisomies were uncomplicated, with the most
common pregnancy complication being polyhydramnios.
While many T18 and T13 cases died spontaneously in-
utero, almost half of cases in both trisomy cohorts sur-
vived for some time following birth. In line with other re-
ports, we found that most liveborn T18 and T13 fetuses
survived for a very short period of time, with T18 female
infants surviving for a longer period of time than T18
male infants; however, one T13 infant from the series is
still alive at (currently) two years of age.
Strengths
This research is strengthened by the fact that all cases
included in the study were definitively diagnosed by
means of fetal karyotyping either prenatally or postna-
tally. Permission was granted to examine the birth re-
cords of all maternity hospitals caring for births in the
region during the time period specified. Also, the relevant
pregnancy chart was obtained for each case identified. In
addition, each case was verified using the EUROCAT
database. This contributed to the inclusiveness and com-
pleteness of the study. The low rate of elective termination
of pregnancy for both trisomies (T18 6%; T13 4%) also
strengthens the study, as the vast majority of pregnant
women chose to continue with affected pregnancies. This
is in contrast to studies that report high rates of elective
termination of pregnancy [9].
Limitations
The main limitation of this study is its small sample size,
which is related to the low prevalence of the trisomies.
Our sample size, however, is larger than that in many
previously published studies. Our study also relied on
Houlihan and O’Donoghue BMC Pregnancy and Childbirth 2013, 13:209 Page 8 of 9
http://www.biomedcentral.com/1471-2393/13/209accurate documentation of the course of affected preg-
nancies in written medical records. It is difficult to be
certain that all of the information recorded in each chart
is completely accurate, especially if some was written
retrospectively resulting in recall bias.
Interpretation
This information relating to the natural history of T18
and T13 pregnancies should be of benefit internation-
ally. It is important that, on receiving a fetal diagnosis of
T18 or T13, parents are assisted to make an informed
decision when determining whether to continue with the
pregnancy or access termination of pregnancy. While
many parents will chose the latter option, detailed know-
ledge of the likely course of the pregnancy is helpful to
those who chose to continue.
In the Republic of Ireland, prenatal screening for fetal
aneuploidy syndromes is not routinely offered, and na-
tionally around 50% of women are offered a detailed
second trimester anomaly ultrasound scan. The lack of
prenatal screening and structural anomaly scans likely
contributed to the relatively high number of T18 and
T13 fetuses in this study who were not diagnosed until
after birth. A prenatal diagnosis of a T18 or T13 fetus
could enable clinicians to appropriately counsel parents
antenatally and to prepare them for the likely outcome.
An unexpected postnatal diagnosis where there has been
anticipation of a normal outcome can be extremely trau-
matic for parents, who may then have little time to
adjust to the reality of an infant with significant mal-
formations and a high risk of neonatal death. In our
study, one pregnant woman who discovered following
birth that her baby had T18 subsequently suffered an
acute stress reaction requiring psychiatric intervention.
Prenatal anomaly screening and diagnosis has been
reported as a practice of which the majority of both
healthcare professionals and pregnant women are in
favour [21,22].
An important finding in this study is the high rate of
caesarean section performed for T18 and T13 fetuses,
particularly the high rate of emergency deliveries. As the
majority of fetuses who were delivered by emergency
caesarean section had not been prenatally diagnosed, the
question must be raised as to whether obstetricians and
mothers would have chosen this mode of delivery if they
had been aware that the fetus had a lethal aneuploidy
syndrome. Had routine screening for fetal abnormalities
been offered to pregnant women, the antenatal diagnosis
of T18 or T13 may have influenced the delivery method
chosen for the affected fetuses. The increased risks of
emergency caesarean section compared with other modes
of delivery are well documented in the literature, as are
the potential implications of undergoing an emergency
caesarean section for subsequent pregnancies [24].Conclusion
This study represents one of the largest recent case
series detailing the natural history of T18 and T13 preg-
nancies. Due to the increasing prevalence of these aneu-
ploidy syndromes and their relative rarity, these reports
are necessary to provide healthcare professionals with an
indication of the potential course of the pregnancies,
and to facilitate appropriate parental counseling. As
many published studies of the natural history of T18 and
T13 pregnancies are limited by small sample sizes, a
meta-analysis of previously published data could be of
benefit in increasing the statistical power of findings.
Also, specific clinical guidelines for the management of
pregnancies with a fetal diagnosis of T18 and T13,
detailing the potential outcomes and complications of
these pregnancies, in addition to the likelihood of each
of these occurring, would be beneficial for healthcare
professionals caring for affected pregnancies.
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